Application no. and date | 01972254.5 (espacenet) (Federated) (European Patent Register), 20010928 | Patent/reg. no. and date | DK/EP 1325000, 20070725 | Publication date | 20030709 | Priority no. and date | GB 0023970, 20000929 | EP pub. no. and date |
EP 1325000 20030709 | Effective date | | Applicant/owner | SMITHKLINE BEECHAM PLC, 980 Great West Road
Brentford, Middlesex TW8 9GS, GB | Applicant ref. no. | P8070468DK00E | Inventor | MILLAN, Michael, C/o GlaxoSmithKline, Old Powder Mills, Near Leigh
Tonbridge, Kent TN11 9AN, GB | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/4439 (2006.01) , A61P 3/10 (2006.01) , C07D 417/12 (2006.01) | Title | Thiazoldiendionderivat og dets anvendelse som antidiabetisk middel | Int. application no. | GB2001004346 | Int. publication no. | WO2002026736 | Related patent (certificate) | | Status | Ophævet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|